These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 14965255)

  • 21. A review on the molecular mechanisms involved in the placental barrier for drugs.
    Marin JJ; Briz O; Serrano MA
    Curr Drug Deliv; 2004 Jul; 1(3):275-89. PubMed ID: 16305390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Placental Barrier: the Gate and the Fate in Drug Distribution.
    Tetro N; Moushaev S; Rubinchik-Stern M; Eyal S
    Pharm Res; 2018 Feb; 35(4):71. PubMed ID: 29476301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placental ABC Transporters: Biological Impact and Pharmaceutical Significance.
    Joshi AA; Vaidya SS; St-Pierre MV; Mikheev AM; Desino KE; Nyandege AN; Audus KL; Unadkat JD; Gerk PM
    Pharm Res; 2016 Dec; 33(12):2847-2878. PubMed ID: 27644937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current toxicological aspects on drug and chemical transport and metabolism across the human placental barrier.
    Giaginis C; Theocharis S; Tsantili-Kakoulidou A
    Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1263-75. PubMed ID: 22780574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug Transporters Expressed in the Human Placenta and Models for Studying Maternal-Fetal Drug Transfer.
    Dallmann A; Liu XI; Burckart GJ; van den Anker J
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1(Suppl 1):S70-S81. PubMed ID: 31502693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug transport across the placenta.
    Eshkoli T; Sheiner E; Ben-Zvi Z; Holcberg G
    Curr Pharm Biotechnol; 2011 May; 12(5):707-14. PubMed ID: 21342126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Models for placental transfer studies of drugs.
    Bourget P; Roulot C; Fernandez H
    Clin Pharmacokinet; 1995 Feb; 28(2):161-80. PubMed ID: 7736690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methodological Approaches to Evaluate Fetal Drug Exposure.
    Bouazza N; Foissac F; Hirt D; Urien S; Benaboud S; Lui G; Treluyer JM
    Curr Pharm Des; 2019; 25(5):496-504. PubMed ID: 30892158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drugs in pregnancy: Pharmacologic and physiologic changes that affect clinical care.
    Pinheiro EA; Stika CS
    Semin Perinatol; 2020 Apr; 44(3):151221. PubMed ID: 32115202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological barriers, and the influence of protein binding on the passage of drugs across them.
    Wanat K
    Mol Biol Rep; 2020 Apr; 47(4):3221-3231. PubMed ID: 32140957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug disposition and pharmacokinetics in the maternal-placental-fetal unit.
    Krauer B; Krauer F; Hytten FE
    Pharmacol Ther; 1980; 10(2):301-28. PubMed ID: 7413726
    [No Abstract]   [Full Text] [Related]  

  • 32. ATP-binding cassette efflux transporters in human placenta.
    Ni Z; Mao Q
    Curr Pharm Biotechnol; 2011 Apr; 12(4):674-85. PubMed ID: 21118087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How impervious is the placental barrier?
    Beck CC
    Vet Med Small Anim Clin; 1973 May; 68(5):468-80. PubMed ID: 4575328
    [No Abstract]   [Full Text] [Related]  

  • 34. The emerging importance of transporter proteins in the psychopharmacological treatment of the pregnant patient.
    Wang JS; Newport DJ; Stowe ZN; Donovan JL; Pennell PB; DeVane CL
    Drug Metab Rev; 2007; 39(4):723-46. PubMed ID: 18058331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New aspects in placental drug transfer.
    Holcberg G; Tsadkin-Tamir M; Sapir O; Huleihel M; Mazor M; Ben Zvi Z
    Isr Med Assoc J; 2003 Dec; 5(12):873-6. PubMed ID: 14689756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug transfer across the placenta. Considerations in treatment and research.
    Simone C; Derewlany LO; Koren G
    Clin Perinatol; 1994 Sep; 21(3):463-81. PubMed ID: 7982330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The contribution of transplacental clearances and fetal clearance to drug disposition in the ovine maternal-fetal unit.
    Szeto HH; Umans JG; Rubinow SI
    Drug Metab Dispos; 1982; 10(4):382-6. PubMed ID: 6126338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear receptors in regulation of biotransformation enzymes and drug transporters in the placental barrier.
    Pavek P; Smutny T
    Drug Metab Rev; 2014 Feb; 46(1):19-32. PubMed ID: 24020384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing drug transport across the human placental barrier: from in vivo and in vitro measurements to the ex vivo perfusion method and in silico techniques.
    Giaginis C; Tsantili-Kakoulidou A; Theocharis S
    Curr Pharm Biotechnol; 2011 May; 12(5):804-13. PubMed ID: 21480826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placental control of drug delivery.
    Al-Enazy S; Ali S; Albekairi N; El-Tawil M; Rytting E
    Adv Drug Deliv Rev; 2017 Jul; 116():63-72. PubMed ID: 27527665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.